Fundraising

uniQure

uniQure Raises $345M in Public Offering

1998
Founded
500+
Employees
Amsterdam, Netherlands
2 min read

Quick Facts

uniQure Raises $345M in Public Offering


uniQure has successfully raised $345M in a Public Offering led by Public Markets.


Company Overview


uniQure is a HealthTech company headquartered in Amsterdam, Netherlands, founded in 1998 with 500+ employees.


Gene therapy company treating Huntington's disease


Fundraising Details


  • Amount Raised: $345M
  • Round Type: Public Offering
  • Date: 2025-09-25
  • Investors: Public Markets

About uniQure


Gene therapy company treating Huntington's disease The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Amsterdam, Netherlands
  • Founded: 1998
  • Team Size: 500+
  • Industry: HealthTech

What This Means


This funding round demonstrates strong investor confidence in uniQure's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. uniQure's successful fundraising reflects the strong fundamentals and growth potential in this space.


Looking Ahead


With this new capital, uniQure is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-09-25. For more information about uniQure, visit their headquarters at Amsterdam, Netherlands.

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news